20

SmithKline Beecham win Queen's award again

SmithKline Beecham's topical antibacterial. mupirocin ("Bactroban') has won the Queen's award for Technological Achievement. This is the second consecutive year that the company has received the award.

'Bactroban' is active against methicillin­resistant Staphylococcus aureus. an organism responsible for fatal hospital epidemics in the I 980s.

THERAPY

'Bactroban' ointment was launched in the UK in the mid-80s and is currently available in almost 40 countries worldwide. In 1988 the nasal formulation became available and is valuable in preventing the spread of infection of this organism which is carried in the nose. '!o'

2 May 1992INPHARMAe ISSN 0156-2703/92/0502-0020/$1.00/0 © Adj. Intematiolloilld